Skip to main content
. Author manuscript; available in PMC: 2020 Oct 30.
Published in final edited form as: Curr Otorhinolaryngol Rep. 2018 Mar 7;6(1):1–14. doi: 10.1007/s40136-018-0181-9

Table 1.

IL-1-mediated Mechanisms of Cancer Promotion

Angiogenesis, IL-1-dependent VEGF production, increased VEGFR
Generation of Myeloid-derived Suppressor Cells (MDSC)
Elevated IL-8 and chemokines, including monocyte chemotaxis (for MDSC)
Migration of endothelial precursors into tumors
Increased basic FGF, PDGF, IL-6 and other stromal growth factors
Neutrophil accumulation in tumor
Growth factor production (GM-CSF, FGF, IL-6, IL-1, chemokines)
Thrombocytosis, platelet-derived IL-1α
Induction of matrix metalloproteinases (MMP) for local spread
Cyclooxygenase (increased PGE2) for immunosuppression
Immunosuppression (increased PD-l ligand and CTLA-4)
Low IL-1Ra circulating levels due to high uric acid levels
Increased endothelial tissue factor for coagulopathy
Increased ICAM-1, increased VCAM-1 for local and metastatic tumor spread